The shortage of the antibiotic began in October 2022 and was most recently expected to resolve in late April. However, now major drugmakers like Hikma, Sandoz and Teva say their amoxicillin stock is still suffering.
According to the ASHP update, Hikma does have oral prescriptions of the drug available, but only for current customers. Sandoz cited several dosage levels of the drug that are currently on backorder, and it did not give an estimated resupply date. Teva is anticipating its short supply to be restocked in early-June.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.